117th Congress · HOUSE BILLBILL

H.R. 7032 — Increasing Transparency in Generic Drug Applications Act of 2022

“To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(j)) with respect to a process to inform persons submitting an abbreviated application for a new drug whether the new drug is qualitatively or quantitatively the same as a listed drug, and for other purposes.”

Health

Introduced Mar 9, 2022

Last action Mar 10, 2022

Pipeline · Bill → Law

Step 1

Introduced

Mar 9, 2022

Step 2

Referred

Mar 10, 2022

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryNo summary available

No CRS summary available for this bill.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Mar 10, 2022

Referred to the Subcommittee on Health.

Mar 9, 2022

Introduced in House

Mar 9, 2022

Referred to the House Committee on Energy and Commerce.